Phone 088 97 25 214
We aim to identify new therapeutic targets for diffuse midline glioma by using CRISPR-Cas9 genetic screening, both in vitro and in vivo.
Identification of therapeutic targets for diffuse midline glioma by functional genetic screening
We aim to identify new therapeutic targets for diffuse midline glioma by using CRISPR-Cas9 genetic screening, both in vitro and in vivo.